Initiation of drug therapy is generally recommended in a monitored inpatient setting, especially in patients with known structural heart disease or risk factors for toxicity.

• 一般来讲，推荐住院患者进行上诉药物治疗（在严密监控下），尤其是患有器质性心脏病或有毒性风险因素的患者。